• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用多尺度方法解析严重急性呼吸综合征冠状病毒2主要蛋白酶机制

Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods.

作者信息

Ramos-Guzmán Carlos A, Ruiz-Pernía J Javier, Tuñón Iñaki

机构信息

Departamento de Química Física, Universidad de Valencia, 46100 Burjassot, Spain.

出版信息

ACS Catal. 2020;10:12544-12554. doi: 10.1021/acscatal.0c03420. Epub 2020 Sep 28.

DOI:10.1021/acscatal.0c03420
PMID:34192089
Abstract

We present a detailed theoretical analysis of the reaction mechanism of proteolysis catalyzed by the main protease of SARS-CoV-2. Using multiscale simulation methods, we have characterized the interactions established by a peptidic substrate in the active site, and then we have explored the free energy landscape associated with the acylation and deacylation steps of the proteolysis reaction, characterizing the transition states of the process. Our mechanistic proposals can explain most of the experimental observations made on the highly similar ortholog protease of SARS-CoV. We point to some key interactions that may facilitate the acylation process and thus can be crucial in the design of more specific and efficient inhibitors of the main protease activity. In particular, from our results, the P1' residue can be a key factor to improve the thermodynamics and kinetics of the inhibition process.

摘要

我们对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶催化的蛋白水解反应机制进行了详细的理论分析。使用多尺度模拟方法,我们表征了肽底物在活性位点建立的相互作用,然后探索了与蛋白水解反应的酰化和脱酰化步骤相关的自由能景观,表征了该过程的过渡态。我们的机理推测可以解释对SARS高度相似的直系同源蛋白酶所做的大多数实验观察结果。我们指出了一些可能促进酰化过程的关键相互作用,因此这些相互作用在设计更具特异性和高效性的主要蛋白酶活性抑制剂方面可能至关重要。特别是,从我们的结果来看,P1'残基可能是改善抑制过程的热力学和动力学的关键因素。

相似文献

1
Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods.运用多尺度方法解析严重急性呼吸综合征冠状病毒2主要蛋白酶机制
ACS Catal. 2020;10:12544-12554. doi: 10.1021/acscatal.0c03420. Epub 2020 Sep 28.
2
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches.使用多尺度计算方法揭示SARS-CoV-2木瓜样蛋白酶的催化机制以及C270突变的变构调节
Chem Sci. 2023 Apr 11;14(18):4681-4696. doi: 10.1039/d3sc00166k. eCollection 2023 May 10.
3
Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.多尺度模拟揭示酮类抑制剂对 SARS-CoV-2 主蛋白酶的抑制机制:改进设计的见解*。
Angew Chem Int Ed Engl. 2021 Dec 1;60(49):25933-25941. doi: 10.1002/anie.202110027. Epub 2021 Nov 3.
4
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.肽醛抑制剂挑战了 SARS-CoV 主蛋白酶的底物特异性。
Antiviral Res. 2011 Nov;92(2):204-12. doi: 10.1016/j.antiviral.2011.08.001. Epub 2011 Aug 11.
5
Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic.跨膜蛋白酶丝氨酸 2 对 SARS-CoV-2 刺突蛋白的蛋白水解切割:激发设计新药以对抗 COVID-19 大流行的机制量子力学/分子力学研究。
J Chem Inf Model. 2022 May 23;62(10):2510-2521. doi: 10.1021/acs.jcim.1c01561. Epub 2022 May 12.
6
A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.SARS-CoV-2主要蛋白酶受迈克尔受体抑制作用的微观描述。改进抑制剂设计的策略。
Chem Sci. 2021 Jan 29;12(10):3489-3496. doi: 10.1039/d0sc04978f.
7
Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.严重急性呼吸综合征冠状病毒(SARS-CoV)3CL蛋白酶半胱氨酸蛋白酶的稳态和预稳态动力学评估:催化离子对模型的建立
Biochemistry. 2008 Feb 26;47(8):2617-30. doi: 10.1021/bi702107v. Epub 2008 Feb 1.
8
Understanding the mechanism of deacylation reaction catalyzed by the serine carboxyl peptidase kumamolisin-As: insights from QM/MM free energy simulations.理解丝氨酸羧基肽酶 Kumamolisin-As 催化的脱酰反应机制:来自 QM/MM 自由能模拟的见解。
J Phys Chem B. 2010 Aug 19;114(32):10594-600. doi: 10.1021/jp102785s.
9
Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.蛋白质结构异质性:SARS-CoV 和 SARS-CoV-2 主要蛋白酶进行蛋白水解识别的基础假说。
Biochimie. 2021 Mar;182:177-184. doi: 10.1016/j.biochi.2021.01.010. Epub 2021 Jan 20.
10
Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.通过基质辅助激光解吸/电离飞行时间质谱对严重急性呼吸综合征(SARS)冠状病毒3C样蛋白酶的底物特异性进行基于肽的快速筛选。
Protein Sci. 2006 Apr;15(4):699-709. doi: 10.1110/ps.052007306.

引用本文的文献

1
Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease.对严重急性呼吸综合征冠状病毒2型主要蛋白酶的腈类和炔类共价抑制剂的作用机制见解
ACS Catal. 2025 Jan 17;15(2):1158-1169. doi: 10.1021/acscatal.4c06020. Epub 2025 Jan 5.
2
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.猴痘病毒I7L蛋白酶的动态帽介导底物进入及强效抑制剂设计
Adv Sci (Weinh). 2025 Jul;12(26):e2501625. doi: 10.1002/advs.202501625. Epub 2025 Apr 7.
3
A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats.
关于利用分子模拟应对新冠疫情威胁的思考
J Phys Chem Lett. 2025 Apr 3;16(13):3249-3263. doi: 10.1021/acs.jpclett.4c03654. Epub 2025 Mar 21.
4
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.探索新型冠状病毒主要蛋白酶的共价抑制剂:从拟肽到新型骨架
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2460045. doi: 10.1080/14756366.2025.2460045. Epub 2025 Feb 6.
5
Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics.通过稳态和预稳态动力学确定的新型冠状病毒3-胰凝乳蛋白酶样蛋白酶的催化机制
ACS Catal. 2024 Nov 27;14(24):18292-18309. doi: 10.1021/acscatal.4c04695. eCollection 2024 Dec 20.
6
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.新型冠状病毒 3- 糜蛋白酶样蛋白酶(3CLpro):作为分子靶标的验证、新型催化机制的提出以及临床前和临床试验中的抑制剂。
Viruses. 2024 May 24;16(6):844. doi: 10.3390/v16060844.
7
Sensitive detection of SARS-CoV-2 main protease 3CL with an engineered ribonuclease zymogen.用工程化核酶原对 SARS-CoV-2 主蛋白酶 3CL 进行灵敏检测。
Protein Sci. 2024 Apr;33(4):e4916. doi: 10.1002/pro.4916.
8
Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2.用于快速筛选针对 SARS-CoV-2 主蛋白酶抑制剂的生物工程淀粉样肽。
Nat Commun. 2024 Mar 7;15(1):2108. doi: 10.1038/s41467-024-46296-7.
9
Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2' proline of the viral polyprotein.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶选择性的研究揭示了病毒多聚蛋白P2'脯氨酸的重要性。
RSC Chem Biol. 2023 Oct 24;5(2):117-130. doi: 10.1039/d3cb00128h. eCollection 2024 Feb 7.
10
BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease.BRD4354是一种针对新型冠状病毒主要蛋白酶的强效共价抑制剂。
Biochemistry. 2024 Feb 8. doi: 10.1021/acs.biochem.3c00685.